Oral glucose-lowering drugs and long-term risk of benign prostatic hyperplasia

Oral glucose-lowering drugs and long-term risk of benign prostatic hyperplasia

Background. One of the most prominent threats for masculine health is comorbidity between benign prostatic hyperplasia (BPH) and diabetes mellitus type 2. Many publications suppose influence of hyperglycemia on lower urinary tract obstruction. Question about influence of the most common oral glucose...

Full description

Saved in:
Bibliographic Details
Main Authors: Stanislav N. Volkov, Robert K. Mikheev, Olga R. Grigoryan, Vitaliy I. Tereshchenko, Vladimir S. Stepanchenko, Elena N. Andreeva
Format: Article
Language:Russian
Published: ZAO "Consilium Medicum" 2024-01-01
Series:Consilium Medicum
Subjects:
benign prostatic hyperplasia
diabetes mellitus
metformin
glimepiride
urology
Online Access:https://consilium.orscience.ru/2075-1753/article/viewFile/121810/162133
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items